Editor
Beijing places missile launchers on disputed South China Sea island
China has placed surface-to-air missile equipment on one of the disputed islands in the South China Sea, newly published satellite images appear to show.
China...
New report urges Africa to address fragility through natural resources management
The African Development Bank Group (AfDB) and the Washington-based Environmental Law Institute (ELI) have produced a new report on natural resources management in fragile...
10 reasons to watch Africa in 2016
Caroline Kende-Robb, Executive Director, Africa Progress Panel
In 2016, the world faces uncertainty and volatility – as well as huge opportunities for significant progress. Africa...
Saudi Arabia, Russia to freeze oil output at near-record levels
(BLOOMBERG) Saudi Arabia and Russia, the world’s two largest crude producers, agreed to freeze output after talks in Qatar.
The deal to fix production at...
APC say 26 members killed, more hunted down
(PortHarcourt, Nigeria) The All Progressives Congress (APC) in Rivers State has cried out again, saying its members are being hunted down and killed through...
Oil rises on chance of output cuts as producers to meet
By Osamu Tsukimori and Aaron Sheldrick
TOKYO (Reuters) - Oil prices surged to their highest levels in more than a week as news of a...
Chelsea to cope without Terry against PSG
Guus Hiddink has said Chelsea are more than prepared to deal with the absence of injured captain John Terry in their Champions League match...
Risk of EU breaking up is ‘real’, European Council President admits
(theIndependent) The risk of the EU breaking up is “real” and negotiations of the UK’s future membership remain “very fragile”, the President of the...
Mark Zuckerberg ‘has 16 bodyguards to protect him at home’
Mark Zuckerberg has reportedly responded to online threats by hiring 16 bodyguards to protect him at home in California.
The co-founder of Facebook is among...
Cancer researchers claim ‘extraordinary results’ using T-cell therapy
(theGuardian): Scientists are claiming “extraordinary” success with engineering immune cells to target a specific type of blood cancer in their first clinical trials.
Among several...




